Drug-eluting stents and drug-coated balloons in peripheral artery disease;Medikamentenbeschichtete stents und ballone in der behandlung der PAVK

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 4, 2012, Pages 248-261

  Buechel, Roland ^a   Stirnimann, Anne ^a   Zimmer, Roman ^a   Keo, Hak Hong ^a   Groechenig, Ernst ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Angioplasty; Drug coated balloons; Drug eluting stents; Peripheral artery disease

Indexed keywords

CONTRAST MEDIUM; EVEROLIMUS; NITINOL; PACLITAXEL;

ANGIOPLASTY; ARTERY DISEASE; BALLOON; BELOW THE KNEE ARTERIAL DISEASE; CRITICAL LIMB ISCHEMIA; DRUG COATED BALLOON; DRUG ELUTING STENT; DRUG RELEASE; FEMORAL ARTERY DISEASE; HUMAN; HYPERPLASIA; INFORMATION RETRIEVAL; KNEE AMPUTATION; NEOINTIMAL HYPERPLASIA; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVASCULARIZATION; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SURVIVAL;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; LIMB SALVAGE; PERIPHERAL ARTERIAL DISEASE; PROSTHESIS DESIGN; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864221511     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000200     Document Type: Review

References (39)

1. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley C V, Raab G, Storkey H; BASIL trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre randomised controlled trial. Lancet. 2005; 366 (9501): 1925-1934.
2. Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R, Escaned J, Bañuelos C, Jiménez-Quevedo P, Macaya C. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol. 2009; 53 (22): 2053-2060.
3. Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, Khan V. Percutaneous interventions below the knee in patients with critical limb ischemia using drug-eluting stents. J Cardiovasc Surg (Torino). 2010; 51: 183-191.
4. Bosiers M, Hart J P, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006; 14 (2): 63-69.
5. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, Schmidt A, Tessared J, Vinck E, Schwartz LB. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012; 55 (2): 390-398.
6. Dake MD, Ansel GM, Jaf MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Zeller T, Roubin GS, Burket M W, Khatib Y, Snyder SA, Ragheb AO, White JK, On behalf of the Zilver PTX Investigators. Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: 12-month Zilver PTX Randomized Study Results. Circ Cardiovasc Intervent 2011; 4 (5): 495-504.
7. Dake MD, Scheinert D, Tepe G, Tes-sarek J, Fanelli F, Bosiers M, Ruhlmann C, Kavteladze Z, Lottes AE, Ragheb AO, Zeller T; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and ef ectiveness results from the Zilver PTX singlearm clinical study. J Endovasc Ther. 2011; 18 (5): 613-623.
8. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Bérégi J P. Sirolimuseluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002; 106 (12): 1505-1509.
9. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tiel-beek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaf MR, Mudde C, Tielemans H, Beregi J P. Drugeluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superf cial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006; 13 (6): 701-710.
10. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010; 55: 1580-1589.
11. Filion KB, Roy AM, Baboushkin T, Rinfret S, Eisenberg MJ. Cost-Effectiveness of Drug-Eluting Stents Including the Economic Impact of Late Stent T rombosis. Am J Cardiol 2009; 103 (3): 338-344.
12. Gargiulo M, Maioli F, Ceccacci T, Morselli-Labate AM, Faggiolo G, Freyrie A, Giovanette F, Testi G, Muccini N, Stella A. What's next after optimal infrapopliteal angioplasty. Clinical and ultrasonographic results of a prospective single-center study. J Endovasc Ther. 2008; 15 (3): 363-369.
13. Giles K.A., Pomposelli F.B., Ham-dan A.D., Blattman SB, Panossian H, Schermerhorn ML: Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic Intersociety consensus class to outcome in 176 limbs. J Vasc Surg 2008; 48 (1): 128-136.
14. Grant AG, White CJ, Collins TJ, Jenkins JS, Reilly J P, Ramee SR. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv. 2008; 71 (1): 108-111.
15. Karnabatidis D, Spiliopoulous S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, Siablis D. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011; 18 (1): 1-12.
16. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, Verta P, Peng L, Gao X, Schwartz LB. First clinical trial of nitinol self-expanding everolimuseluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011; 54 (2): 394-401.
17. Lookstein R, Ward T, Kim E, Fisch-man A, Nowakowksi F, Ellozy S, Teodorescu V, Vouyouka A, Faries P, Weintraub J. Value of drugeluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results. J Cardiovasc Surg (Torino). 2011; 52 (4): 461-466.
18. Micari A, Cioppa A, Vadalà G, Stabile E, Castriota F, Pantaleo P, Grattoni C, Cremonesi A, Marchese A, Rubino P, Biamino G. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results. EuroIntervention. 2011; 7 Suppl K: K77-82.
19. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlböck M, Seitz W, Wolfram R, Pötter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: Results of a prospective randomized study. Circulation 2000; 102: 2694-2699.
20. Morice MC, Serruys P W, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R. RAVEL Study Group. A Randomized Comparison of a Siroli-mus-Eluting Stent with a Standard Stent for Coronary Revascularization. N Engl J Med 2002; 346 (23): 1773-1780.
21. Norgren L, Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes FG; TASC II working group. Inter-Society Consensus fot the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 Suppl S: S5-67.
22. Rand T, Basile A, Cejna M, Fleis-chmann D, Funovics M, Gschwendtner M, Haumer M, Von Katzler I, Kettenbach J, Lomoschitz F, Luf C, Minar E, Schneider B, Schoder M, Lammer J. PTA versus carbof lmcoated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 2006; 29: 29-38.
23. Rastan A, Schwarzwälder U, Noory E, Taib FH, Beschorner U, Sixt S, Schwarz T, Bürgelin K, Amantea P, Neumann FJ, Zeller T. Primary use of sirolimuseluting stents for angio-plasty of infrapopliteal arteries. J Endovasc Ther 2010; 17 (4): 480-487.
24. Rastan A, Tepe G, Krankenberg H, Zahrosky R, Beschorner U, Noory E, Sixt S, Schwarz T, Brechtel K, Böhme C, Neumann FJ, Zeller T. Sirolimuseluting Stents versus Bare-metal Stents for treatment of focal lesions in infrapopliteal arteries: A double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011; 32: 2274-2281.
25. Rastan A., Noory E., Zeller T., Drug-eluting stents for treatment of focal infrapopliteal lesions. Vasa 2012 (41) 2: 90-95.
26. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug eluting stents: an updated meta-analysis of randomized controlled trials. Heart 2006; 92 (5): 641-649.
27. Romiti M, Albers M, Broschado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47 (5): 975-981.
28. Rosales OR, Mathewkutty S, Gnaim C. Drugeluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc Interv 2008; 72 (1): 112-115.
29. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. He-matopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8 (4): 403-409.
30. Scheinert D, Ulrich M, Scheinert S, Sax J, Braunlich S, Biamino G. Comparison of sirolimuseluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2006; 2 (2): 169-174.
31. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D. First experience with drugeluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011 6; 58 (11): 1105-1109.
32. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a Potential Role fort he Adventitia in Vascular Lesion Formation After Balloon Overstretch Injury of Porcine Coronary Arteries. Circulation 1996; 93 (12): 2178-2187.
33. Shi Y, O'Brien J, Fard A, Mannion J, Wang D, Zalewski A. Adventitial Myofibroblasts Contribute to Neo-intimal Formation in Injured Porcine Coronary Arteries. Circulation 1996; 94 (7): 1655-1664.
34. Shi Y, O'Brien JE Jr, Mannion JD, Morrision RC, Chung W, Fard A, Zalewski A. Remodeling of Autologous Saphenous Vein Grafts. The role of perivascular myofibroblasts. Circulation 1997; 95 (12): 2684-2693.
35. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, Tsolakis J. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limbs ischemia: analysis of long-term angiographic and clinical outcomes. J Vasc Interv Radiol. 2009; 20 (9): 1141-1150.
36. Sigwart U, Puel J, Mirkovitch V, Jof-fre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angio-plasty. N Engl J Med 1987; 316 (12): 701-6.
37. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi J P, Claussen CD, Oldenburg A, Scheller B, Speck U. Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg. N Engl J Med 2008; 358 (7): 689-699.
38. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoro-popliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008; 23; 118 (13): 1358-1365.
39. Zeller T, Sixt S, Rastan A. New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia. Vasa 2009; 38 (1): 3-12.